Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

IASLC Early Detection and Screening Committee: Global obstacles to lung cancer...

Dr Milena Cavic - Institute for Oncology and Radiology of Serbia, Belgrade...

IASLC Early Detection and Screening Committee: Global obstacles to lung cancer screening ( Dr Milena Cavic - Institute for Oncology and Radiology of Serbia, Belgrade, Serbia )

Personalised smoking cessation support in a lung cancer screening programme

Dr Rachael Murray - The University of Nottingham, Nottingham, UK

Personalised smoking cessation support in a lung cancer screening programme ( Dr Rachael Murray - The University of Nottingham, Nottingham, UK )

Early diagnosis needed for young adults with lung cancer

Alexandra Potter - Massachusetts General Hospital, Boston, USA

Early diagnosis needed for young adults with lung cancer ( Alexandra Potter - Massachusetts General Hospital, Boston, USA )

Informed consent forms for lung cancer trials too long and complex for patients

Dr Upal Basu Roy PhD MPH - Executive Director of Research, LUNGevity Foundation...

Informed consent forms for lung cancer trials too long and complex for patients ( Dr Upal Basu Roy PhD MPH - Executive Director of Research, LUNGevity Foundation, Chicago, USA )

Initial steps in creating a patient-centric addendum to clinical trial informed...

Dr Belinda King-Kallimanis - Director of Patient-Focused Research, LUNGevity...

Initial steps in creating a patient-centric addendum to clinical trial informed consent forms ( Dr Belinda King-Kallimanis - Director of Patient-Focused Research, LUNGevity Foundation, Chicago, USA )

Topics under discussion at the WCLC 2022 presidential symposium

Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain

Topics under discussion at the WCLC 2022 presidential symposium ( Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )

Atezolizumab vs best supportive care in resected NSCLC

Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain

Atezolizumab vs best supportive care in resected NSCLC ( Dr Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )

MOUNTAINEER: Tucatinib in combination with trastuzumab for HER2-positive mCRC

Dr Jonathan Strickler - Duke Cancer Institute, Durham, USA

MOUNTAINEER: Tucatinib in combination with trastuzumab for HER2-positive mCRC ( Dr Jonathan Strickler - Duke Cancer Institute, Durham, USA )

Working to improve global cancer care access in low middle-income countries

Dr Julie Gralow, Prof Eduardo Cazap

Working to improve global cancer care access in low middle-income countries ( Dr Julie Gralow, Prof Eduardo Cazap )

Philippines Choosing Wisely guidelines

Dr Frederic Ivan Ting - Chair of the Clinical Consensus Committee, Bacolod...

Philippines Choosing Wisely guidelines ( Dr Frederic Ivan Ting - Chair of the Clinical Consensus Committee, Bacolod, Philippines )

Impact of BRAF-V600E mutation on the tumour microenvironment and associated...

Dr Mohamed Salem - Levine Cancer Institute, Charlotte, USA

Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer ( Dr Mohamed Salem - Levine Cancer Institute, Charlotte, USA )

Prostate cancer screening: A novel risk prediction tool with standard biopsies...

Dr Lars Björnebo - The Karolinska Institute, Solna, Sweden

Prostate cancer screening: A novel risk prediction tool with standard biopsies vs PSA with MRI-targeted biopsies ( Dr Lars Björnebo - The Karolinska Institute, Solna, Sweden )

More from ecancer